Back
Hallador Energy 10K Form
Buy
77
HNRG
Hallador Energy
Last Price:
$18.88
Seasonality Move:
4.85%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | HNRG/Hallador Energy Quarterly |
2023-11-06 | 10Q | HNRG/Hallador Energy Quarterly |
2023-08-07 | 10Q | HNRG/Hallador Energy Quarterly |
2023-05-08 | 10Q | HNRG/Hallador Energy Quarterly |
2022-11-14 | 10Q | HNRG/Hallador Energy Quarterly |
2022-08-15 | 10Q | HNRG/Hallador Energy Quarterly |
Receive HNRG News And Ratings
See the #1 stock for the next 7 days that we like better than HNRG
HNRG Financial Statistics
Sales & Book Value
Annual Sales: | $404.4M |
---|---|
Cash Flow: | $26.7M |
Price / Cash Flow: | 20.4 |
Annual Sales: | $2.68 |
Price / Book: | 6.88 |
Profitability
EPS (TTM): | -5.45000 |
---|---|
Net Income (TTM): | $-214.5M |
Gross Margin: | $225.8M |
Return on Equity: | -94.19% |
Return on Assets: | -42.97% |
Hallador Energy Earnings Forecast
Key Hallador Energy Financial Ratios
-
The Gross Profit Margin over the past 26 years for HNRG is 55.84%.
-
The Selling, General & Administrative Expenses for HNRG have been equal to 35.29% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of HNRG is -55.92% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 12 years.
Hallador Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | HNRG |
CUSIP: | 40609P |
Website: | halladorenergy.com |
Debt
Debt-to-Equity Ratio: | 0.18 |
---|---|
Current Ratio: | 0.6 |
Quick Ratio: | 0.11 |
Price-to-Earnings
Trailing P/E Ratio: | 9.18 |
---|---|
Forward P/E Ratio: | 36.94 |
HNRG Technical Analysis vs Fundamental Analysis
Buy
77
Hallador Energy (HNRG)
is a Buy
Is Hallador Energy a Buy or a Sell?
-
Hallador Energy stock is rated a BuyThe current Hallador Energy [HNRG] share price is $18.47. The Score for HNRG is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.